Table 9.

Effects of the nucleotide complementary to the non-UAG site

	The complementary nucleotide
	C	U	G	A	None	Total
AAG	0/13	10/185	0/11	0/16	0/6	10/231
AAA	3/15	5/205	0/31	0/33	0/12	8/296
UAU	1/13	4/240	0/8	1/20	0/5	6/286
UAC	0/10	5/157	0/8	0/17	0/9	5/201
UAA	0/6	4/164	0/10	0/27	0/11	4/218
CAG	1/19	1/238	0/16	0/15	0/7	2/295
CAC	2/10	0/170	0/6	0/9	0/9	2/204
CAU	1/5	1/221	0/4	0/15	0/13	2/258
CAA	1/7	0/166	0/10	0/18	0/7	1/208
AAC	0/9	1/135	0/13	0/10	0/7	1/174
AAU	0/16	1/190	0/21	0/17	0/10	1/254
GAG	1/14	0/202	0/11	0/17	0/9	1/253
Totala	10/137 (7.3%)	32/2273 (1.4%)	0/149 (0.0%)	1/214 (0.5%)	0/105 (0.0%)	43/2878 (1.5%)

^aEdited and potential non-UAG sites identified in the 209 pri-miRNAs were counted (edited/potential).